Sold Out
Sold Out
Book Categories |
Thalassemia : the continued challenge | 1 | |
Keynote address : the challenge of Thalassemia for the developing countries | 11 | |
Changing patterns of Thalassemia worldwide | 18 | |
[alpha]-Thalassemia : Hb H disease and Hb bans hydrops fetalis | 25 | |
Hemoglobin E-[beta]-Thalassemia : progress report from the international study group | ||
Survival and complications in Thalassemia | ||
Role of intergenic human [gamma]-[delta]-globin sequences in human hemoglobin switching and reactivation of fetal hemoglobin in adult erythroid cells | 48 | |
Isolation and characterization of hematopoietic transcription factor complexes by in Vivo biotinylation tagging and mass spectrometry | ||
Germline epimutation : a basis for epigenetic disease in humans | 68 | |
Progress toward the genetic treatment of the [beta]-Thalassemias | 78 | |
Understanding [alpha]-globin gene regulation : aiming to improve the management of Thalassemia | ||
Role of alpha hemoglobin-stabilizing protein in normal erythropoiesis and [beta]-Thalassemia | 103 | |
Role of iron in inducing oxidative stress in Thalassemia : can it be prevented by inhibition of absorption and by autioxidants? | 118 | |
Objectives and mechanism of iron chelation therapy | 124 | |
Ferritin as an iron concentrator and chelator target | 136 | |
The design of orally active iron chelators | 141 | |
Recent insights into interactions of deferoxamine with cellular and plasma iron pools : implications for clinical use | 155 | |
Deferiprone : new insight | 169 | |
Combined therapy with deferroxamine and deferiprone | 175 | |
Evaluation of ICL670, a once-daily oral iron chelator in a phase III clinical trial of [beta]-Thalassemia patients with transfusional iron overload | 183 | |
Unrelated bone marrow transplantation for [beta]-Thalassemia patients : the experience of the Italian bone marrow transplant group | ||
Bone marrow transplantation in adults with Thalassemia : treatment and long-term follow-up | 196 | |
Sibling donor cord blood transplantation for Thalassemia major : experience of the sibling donor cord blood program | ||
Stem cell transplantation with S-59 photochemically treated T-cell add-backs to establish allochimerism in Murine Thalassemia | 214 | |
Preimplantation genetics : improving access to stem cell therapy | 223 | |
Pharmacological induction of fetal hemoglobin : why haven't we been more successful in Thalassemia? | 228 | |
Successful correction of the human Cooley's anemia [beta]-Thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator | 238 | |
Single and combination plug therapy for fetal hemoglobin augmentation in hemoglobin E-[beta][superscript 0]-Thalassemia : considerations for treatment | ||
Induction of fetal globin in [beta]-Thalassemia : cellular obstacles and molecular progress | 257 | |
Caring for adults with Thalassemia in a pediatric world | 266 | |
Quality of life in Thalassemia | 273 | |
Thalassemia and learning : neurocognitive function in children | 283 | |
Treatment of hepatitis C virus infection in Thalassemia | 290 | |
Fertility and pregnancy in Thalassemia major | 300 | |
A phase I/II clinical trial of [beta]-globin gene therapy for [beta]-Thalassemia | 308 | |
Coagulation and splenectomy : an overview | 317 | |
Transfusion safety : where are we today? | 325 | |
Pulmonary hypertension in [beta]-Thalassemia | 342 | |
Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry | 350 | |
Methods for noninvasive measurement of tissue iron in Cooley's anemia | ||
T2* magnetic resonance and myocardial iron in Thalassemia | 373 | |
Measurement and mapping of liver iron concentrations using magnetic resonance imaging | 379 | |
Physiology and pathophysiology of iron cardiomyopathy in Thalassemia | 386 | |
Eighth Cooley's anemia symposium : summation and perspective | 396 | |
Rescued mice with Hb E transgene-developed red cell changes similar to human [beta]-Thalassemia/HbE disease | 407 | |
Exploring the role of hepcidin, an antimicrobial and iron regulator peptide, in increased iron absorption in [beta]-Thalassemia | ||
Murine and math models for the level of stable mixed chimerism to cure [beta]-Thalassemia by nonmyeloablative bone marrow transplantation | 423 | |
Non-transferrin-bound iron during blood transfusion cycles in [beta]-Thalassemia major | 429 | |
Genetic analysis of candidate modifier polymorphisms in HbE-[beta][superscript 0]-Thalassemia patients | 433 | |
Measuring chromosome breaks in patients with Thalassemia | 439 | |
Longitudinal study of survival and causes of death in patients with Thalassemia major in Greece | 445 | |
Osteoporosis in [beta]-Thalassemia : clinical and genetic aspects | 451 | |
Quality of life in patients with Thalassemia intermedia compared to Thalassemia major | 457 | |
Low bone mineral density in adolescents with [beta]-Thalassemia | 462 | |
Does heterozygous [beta]-Thalassemia confer a protection against coronary artery disease? | 467 | |
Therapeutic approaches to pulmonary hypertension in hemoglobinopathies : efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy | 471 | |
Utility of Holter electrocardiogram in iron-overloaded hemoglobinopathies | 476 | |
Hemolysis-associated pulmonary hypertension in Thalassemia | 481 | |
A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with Thalassemia | ||
Preclinical and clinical development of deferitrin, a novel, orally available iron chelator | 492 | |
Allosensitization in patients receiving multiple blood transfusions | 495 | |
Outcomes of preimplantation genetic diagnosis therapy in treatment of [beta]-Thalassemia : a retrospective analysis | 500 |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionCooley's Anemia: Eighth Symposium
X
This Item is in Your InventoryCooley's Anemia: Eighth Symposium
X
You must be logged in to review the productsX
X
X
Add Cooley's Anemia: Eighth Symposium, Cooley's anemia, or thalassemia major, is a blood disorder characterized by a marked increase in F hemoglobin and a decrease in the production of certain oxygen-carrying proteins in red blood cells. Thalassemia major is the most severe form of the chro, Cooley's Anemia: Eighth Symposium to the inventory that you are selling on WonderClubX
X
Add Cooley's Anemia: Eighth Symposium, Cooley's anemia, or thalassemia major, is a blood disorder characterized by a marked increase in F hemoglobin and a decrease in the production of certain oxygen-carrying proteins in red blood cells. Thalassemia major is the most severe form of the chro, Cooley's Anemia: Eighth Symposium to your collection on WonderClub |